- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 128,040 | 15.07.24 21:39:34 | +0,280 | +0,22% | 128,030 | 128,050 | 128,000 | 127,760 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 97,560 | 15.07.24 21:37:19 | -1,850 | -1,86% | 97,070 | 97,610 | 100,000 | 99,410 |
